Title | A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With HR+/HER2- Advanced or Metastatic Breast Cancer |
---|---|
Disease/Condition | Breast Cancer,Skin Disorders,Medical and Hematologic Oncology,Neoplasms |
Description | |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Sun Young Oh, MD |
Contact Name | Priscilla Vazquez |
Contact Email | pvazquez@montefiore.org |
Protocol Number | 16-06-378-01 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | HR+/HER2- Breast Cancer |
Adult, Pediatric, Both | Adult |